Geron Seeks To Double Authorized Shares To 100M
DOW JONES NEWSWIRES
WASHINGTON -- Geron Corp. (GERN) plans to increase the number of common shares it's authorized to issue to 100 million from 50 million, according to a preliminary proxy filed Friday with the Securities and Exchange Commission.
The biopharmaceutical company's shareholders will have a chance to vote on the proposed increase at their annual meeting, scheduled for May 17 in Redwood City, Calif.
Geron said in the proxy that it may use the shares for raising capital, stock incentives, establishing strategic relationships or acquisitions, though it doesn't have set plans now.
Geron, of Menlo Park, Calif., develops diagnostics for oncology, drug discovery and other medical applications |
